Boussard & Gavaudan Investment Management LLP Qiagen N.V. Transaction History

Boussard & Gavaudan Investment Management LLP

$407 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$42.51 - $52.42 $496,941 - $612,789	-11,690 Closed	0 $0
Q2 2020 Jul 09, 2020	SELL	$39.49 - $44.36 $10.5 Million - $11.8 Million	-266,231 Reduced 95.79%	11,690 $504,000
Q1 2020 May 27, 2020	BUY	$33.17 - $41.6 $2.02 Million - $2.54 Million	60,983 Added 28.11%	277,921 $11.2 Million
Q4 2019 Feb 12, 2020	BUY	$25.41 - $43.1 $5.51 Million - $9.35 Million	216,938 New	216,938 $7.3 Million

Others Institutions Holding QGEN

# of Institutions

Shares Held

6.37M

Call Options Held

Put Options Held

Pendal Group LTD

4.3M
Shares

$178 Million
1.76% of portfolio
Abeille Asset Management Sa

931K
Shares

$38.5 Million
1.68% of portfolio
Grandeur Peak Global Advisors, LLC Salt Lake City, UT

796K
Shares

$32.9 Million
3.21% of portfolio
Pictet Asset Management Sa Geneva 73, V8

153K
Shares

$6.34 Million
0.01% of portfolio
Bdl Capital Management Paris, I0

88.8K
Shares

$3.67 Million
3.33% of portfolio

View Full List

About QIAGEN N.V.

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.41B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

More about QGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boussard & Gavaudan Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Boussard & Gavaudan Investment Management LLP with notifications on news.

Account